https://biotechmorning.com/news/lilly-deal-spree-venture-capital-recycling Biotech Morning en 2026-09-02T14:22:02.625Z Eli Lilly Spent $25 Billion on Deals This Year. Guess Where All That Cash Went. https://biotechmorning.com/news/lupus-humbled-tyk2-drug-alumis Biotech Morning en 2026-09-02T14:21:16.288Z Lupus Just Humbled Another TYK2 Drug https://biotechmorning.com/news/roche-simcere-trispecific-antibody-deal Biotech Morning en 2026-09-02T14:20:27.774Z Roche Just Paid $75M for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/novartis-3-2b-alteogen-subcutaneous-delivery-deal Biotech Morning en 2026-09-02T14:19:40.451Z Novartis Just Paid $3.2B to Kill the IV Drip https://biotechmorning.com/news/novartis-remibrutinib-ms-cheat-code Biotech Morning en 2026-09-02T14:18:55.008Z Novartis Just Found the Cheat Code for Multiple Sclerosis https://biotechmorning.com/news/arpa-h-125m-rna-manufacturing Biotech Morning en 2026-09-02T14:18:08.228Z The Government Wants to 3D-Print Your RNA Medicine https://biotechmorning.com/news/biomx-tessera-defense-phage-therapy-pivot Biotech Morning en 2026-09-02T14:17:16.895Z From Phage Therapy to Homeland Security: Biotech's Wildest Pivot https://biotechmorning.com/news/regeneron-fop-bone-disease-approval Biotech Morning en 2026-09-02T14:16:28.845Z Regeneron Just Crashed the Rarest Bone Disease Party https://biotechmorning.com/news/novo-oral-wegovy-germany-launch Biotech Morning en 2026-09-02T14:15:47.939Z Novo's Weight-Loss Pill Just Landed in Europe. Now the Real Test Begins. https://biotechmorning.com/news/arsenal-bio-torches-playbook-pivots-in-vivo-car-t Biotech Morning en 2026-09-02T14:15:02.000Z Arsenal Bio Just Torched Its Own Playbook. Here's Why. https://biotechmorning.com/news/mrna-cancer-vaccine-hits-wall Biotech Morning en 2026-09-02T14:14:14.918Z The mRNA Cancer Vaccine That Hit a Wall Nobody Saw Coming https://biotechmorning.com/news/parse-biosciences-patent-verdict-single-cell-sequencing Biotech Morning en 2026-09-01T14:15:18.981Z A $4.8M Verdict That Could Redraw the Single-Cell Sequencing Map https://biotechmorning.com/news/oral-relaxin-heart-failure-comeback Biotech Morning en 2026-09-01T14:14:30.850Z The Heart Failure Drug That Keeps Coming Back From the Dead https://biotechmorning.com/news/car-t-autoimmune-safety-crisis-novartis-bms Biotech Morning en 2026-09-01T14:13:38.927Z CAR-T's Worst Week Just Threatened Its Most Exciting Frontier https://biotechmorning.com/news/fda-commissioner-kalvista-drug-rejection-staff-pushback Biotech Morning en 2026-09-01T14:12:57.183Z The FDA Commissioner Tried to Kill a Drug Approval. His Own Staff Said No. https://biotechmorning.com/news/sanofi-backed-electra-nasdaq-ipo-filing Biotech Morning en 2026-09-01T14:12:12.622Z Sanofi's Secret Weapon Just Filed to Go Public https://biotechmorning.com/news/drug-pricing-squeeze-midsize-biotech Biotech Morning en 2026-09-01T14:11:30.571Z The Drug Pricing Squeeze Just Moved Down the Food Chain https://biotechmorning.com/news/samsung-biologics-polypeptide-group-takeover Biotech Morning en 2026-09-01T14:10:47.062Z Samsung Biologics Just Bet $1.8B That Peptides Are the Future https://biotechmorning.com/news/gsk-mrna-flu-vaccine-phase-3 Biotech Morning en 2026-09-01T14:10:01.140Z GSK's Flu Shot Just Beat the Old Guard. Now Comes the Hard Part. https://biotechmorning.com/news/tagrisso-orpathys-egfr-lung-cancer-combo Biotech Morning en 2026-09-01T14:09:17.376Z Tagrisso's $6 Billion Fortress Just Got a New Weapon